The Public Record
Michael Clifton Burgess is an American politician and physician who has served as the U.S. Representative for Texas's 26th congressional district since 2003. A member of the Republican Party, Burgess has focused on healthcare policy, leveraging his medical background to inform his legislative work. He has been involved in various committees and has advocated for issues such as medical research and veterans' healthcare. Burgess has also been a vocal supporter of conservative fiscal policies and has participated in discussions surrounding healthcare reform.
Today I rise to speak in honor of our guest chaplain, Marshall Dunbar, of Cross Roads, Texas. Chaplain Dunbar is the vice president of Spiritual Life and interim vice president of Programs for Christian Community Action, one of the largest…
The Independent Payment Advisory Board was not supported by a single Republican in the 109th Congress.
I would like to thank Representative Dingell for working with me on two of the bills that we will be considering today, H.R. 3120 and H.R. 3263.
Each of these policies exemplifies our shared commitment to strengthening the Medicare program for current beneficiaries, and improving it for future generations.
Number one, it is not germane, and it is more complicated now because the Food and Drug Administration has gotten involved in the process. I wish it were straightforward. It is something I continue to work on.
By direction of the Committee on Rules, I call up House Resolution 451 and ask for its immediate consideration. The Clerk read the resolution, as follows: H. Res. 451 Resolved, That at any time after adoption of this resolution the Speaker…
House Resolution 451 provides for a structured rule to consider a bill out of the Energy and Commerce Committee pertaining to the Environmental Protection Agency's ozone standards. The rule provides for 1 hour of debate equally divided…
The reason is because the manufacture of over-the- counter epinephrine inhalers has been prohibited by the EPA and the Food and Drug Administration.
As Chairman Walden pointed out, this program has saved billions of dollars for patients, ensuring that those in need could receive care and that the hospitals that provide that care can continue to support their communities.
I thank the chairman for yielding me the time. It is significant today to be here and be supporting H.R. 2430, the Food and Drug Administration Reauthorization Act of 2017. The passage of this bill provides certainly the security to the…
I feel they offer a targeted approached to addressing the problems presented by our regulatory framework for medical product communication.
From last year's 21st Century Cures Act to this year's Food and Drug Administration reauthorization, this subcommittee has been committed to bringing Federal regulation into the modern era of medicine.
Politicians like Michael Burgess
